Winner Profile
Xiaoqing Yao
CEO, Tianjin Chase Sun Pharmaceutical
Industry: Pharmaceuticals
Company size: Large
Published: 2016-10-17
Is Tianjin Chase Sun Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Xiaoqing Yao (Tianjin Chase Sun Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Xiaoqing Yao
Xiaoqing Yao was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Xiaoqing Yao
In summary, Xiaoqing Yao obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 78 in Combined Performance indicates that Xiaoqing Yao was better than 78% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for three participations in Obermatt CEO competitions. Xiaoqing Yao’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.